UBS Affirms Merck & Co’s (MRK) ‘Buy’ Rating on HPV Vaccine Prospects

finance.yahoo.com/news/ubs-affirms-merck-co-mrk-130937251.html

In This Article:
Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ‘Buy’ rating on the stock and a $105 price target. According to analyst Trung Huynh, the company’s human papillomavirus (HPV) vaccine, Gardasil,…

This story appeared on finance.yahoo.com, 2025-07-09 13:09:37.
The Entire Business World on a Single Page. Free to Use →